USCOM in Newly Diagnosed FGR Cases

Key facts

Sponsor

Icahn School of Medicine at Mount Sinai

Principal Investigator

Nicola F Tavella, MPH

Icahn School of Medicine at Mount Sinai

Intervention

USCOM(device)

Enrollment

100 target

Eligibility

18 years · All sexes

Timeline

2024 – 2026

Study locations (1)

• Mount Sinai Hospital, New York, New York, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Placental insufficiency

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07098975
  Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• RECRUITINGNCT07470320
  Placental Biology in Health and Disease
  University of Oxford
• RECRUITINGPHASE3NCT06723392
  Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
  NICHD Global Network for Women's and Children's Health
• RECRUITINGNCT07144839
  Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
  Oregon Health and Science University
• RECRUITINGNCT06861309
  Placental Imaging Techniques
  Carilion Clinic
• RECRUITINGPHASE3NCT06497959
  Study of Placental Vascularization Using Contrast Ultrasound
  Central Hospital, Nancy, France
• RECRUITINGNCT06893926
  Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
  Institute of Mother and Child, Warsaw, Poland
• ACTIVE NOT RECRUITINGNANCT06315127
  The CanDo (Canadian Donor Milk) Trial
  Mount Sinai Hospital, Canada

See all trials for Placental insufficiency →